share_log

Guggenheim Initiates Coverage On Zura Bio With Buy Rating, Announces Price Target of $20

Benzinga ·  Jun 22, 2023 09:28

Guggenheim analyst Yatin Suneja initiates coverage on Zura Bio (NASDAQ:ZURA) with a Buy rating and announces Price Target of $20.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment